<Disease><Name>APOLIPOPROTEIN C-II DEFICIENCY</Name><Synonym>HYPERLIPOPROTEINEMIA TYPE I</Synonym><OMIM><Number>207750</Number><URL>http://omim.org/entry/207750</URL></OMIM><Orphanet><Number>309020</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=309020</URL></Orphanet><Protein><Number>Apolipoprotein C-II</Number><URL>http://www.uniprot.org/uniprot/P02655</URL></Protein><ExPASy><Number /><URL /></ExPASy><Gene>19q13.32</Gene><ICD>E78.3</ICD><Summary>rare (30 cases) ;autosomal recessive;mutation in the APOC2 gene</Summary><Symptoms><symtomp><id>2347</id><symptom>anemia</symptom><category>IMMUNE OR HEMATOLOGIC SYSTEM | LABORATORY FINDINGS</category></symtomp><symtomp><id>1994</id><symptom>hepatomegaly (large liver)</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>3179</id><symptom>lipemia retinalis</symptom><category>EYES</category></symtomp><symtomp><id>2506</id><symptom>onset, adolescent / adolescence</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1975</id><symptom>pain, abdominal / pain abdominal</symptom><category>BODY | GENERAL TOPICS</category></symtomp><symtomp><id>2210</id><symptom>pancreatitis</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2593</id><symptom>recent memory loss</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2042</id><symptom>splenomegaly (large spleen)</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>3172</id><symptom>xanthoma</symptom><category>SKIN</category></symtomp></Symptoms><Metabolites><metabolite><id>295</id><name>Cholesterol</name><specimen>serum</specimen><value>increased</value><min>3.60</min><max>8.00</max><unit>mmol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>312</id><name>Cholesterol</name><specimen>serum</specimen><value>increased</value><min>1.40</min><max>3.50</max><unit>mmol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>313</id><name>Cholesterol</name><specimen>serum</specimen><value>increased</value><min>1.80</min><max>4.50</max><unit>mmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>314</id><name>Cholesterol</name><specimen>serum</specimen><value>increased</value><min>3.10</min><max>5.20</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1006</id><name>Cholesterol</name><specimen>serum</specimen><value>increased</value><min>120.00</min><max>200.00</max><unit>mg/dl</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1016</id><name>Chylomicrons</name><specimen>plasma</specimen><value>increased</value><min>    </min><max>    </max><unit>absent</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>294</id><name>Triglycerides</name><specimen>serum</specimen><value>increased</value><min>40.00</min><max>128.00</max><unit>mg/dl</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>491</id><name>Triglycerides</name><specimen>serum</specimen><value>increased</value><min>30.00</min><max>99.00</max><unit>mg/dl</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1008</id><name>Triglycerides</name><specimen>various tissues</specimen><value>increased</value><min>    </min><max>    </max><unit>no data</unit><age>child</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>1237</id><title>Apolipoprotein C-II deficiency presenting as a lipid encephalopathy in infancy</title><author>Wilson CJ</author><journal>Ann Neurol</journal><year>2003</year><book /><volume>53</volume><number>6</number><pages>807-810</pages><co_aut>et al.</co_aut></literature><literature><id>1629</id><title>A case of apolipoprotein C-II deficiency with coronary artery disease</title><author>Kawano M</author><journal>Clin Exp Med</journal><year>2002</year><book /><volume>2</volume><number>1</number><pages>29-31</pages><co_aut>et al.</co_aut></literature><literature><id>1630</id><title>Farnesoid X-activated receptor induces apolipoprotein C-II transcription: a molecular mechanism linking plasma triglyceride lev</title><author>Kast HR</author><journal>Mol Endocrinol</journal><year>2001</year><book /><volume>15</volume><number>10</number><pages>1720-1728</pages><co_aut>et al.</co_aut></literature><literature><id>1631</id><title>Apolipoprotein C-II deficiency</title><author>Okamoto Y</author><journal>Nippon Rinsho</journal><year>2001</year><book /><volume>59</volume><number>3</number><pages>26-31</pages><co_aut /></literature><literature><id>1632</id><title>A thymidine to cytosine substitution for codon 26 of exon 3 of apolipoprotein C-II gene in a patient with apolipoprotein C-II d</title><author>Kuniyoshi A</author><journal>Intern Med</journal><year>1999</year><book /><volume>38</volume><number>2</number><pages>140-144</pages><co_aut>et al.</co_aut></literature><literature><id>78</id><title>Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome</title><author>Brunzell JD</author><journal>The metabolic and molecular bases of inherited disease, 7/e; Editors: C.R.Scriver, A.L.Beaudet, W.S.Sly, D.Valle; McGraw-Hill Inc.</journal><year>1995</year><book /><volume>2</volume><number>0</number><pages>1913-1932</pages><co_aut /></literature></Literatures></Disease>